George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Nice and simple promotional. Like that a lot.
Mornington-oz. 6.79 would you believe. Not my best entry point of the last 12 months.
It will need to be brewing for a long time for me to recoup my current losses. :) A looooong time.
Still, I'll accept any short term brewing as positive.
Sounding positive. Much better outlook than 2 months prior with all the dreaded CLNs. Onwards and upwards. Thanks for summary.
Missed it too. JHFH, would you be so kind as to give us the headlines?
A fair summary Pokerchips, but in terms of the realistic value of the company?
All sounding positive but the price action has been woeful since admission to LSE. Any thoughts on where the bottom is here? We are now below opening price? Anyone done any fag packet market cap prediction based on current product line only?
That my good man, is a particularly wild prediction. They have cash in the bank and are pushing on with a name change and subsequent realigned strategy. Interested to know the basis for your thoughts?
Yesterdays rise was quite something. It wouldn't be normal for there not to be a slight pull back and consolidation today. Id be more worried personally if we did another 20 today. Patience is required, although I understand a few LTHs will have been underwater for a while. I am myself.
The Govnor78... Spot on.
Probably the biggest positive is the board seems pretty civilised at the moment... A few others im on are a shambles. No names....
Cheers readicant. Will have another look. Im invested but I've not been following news, although there's obviously not been a great deal of market sensitive stuff going on of late.
Indeed. Its a steady decline sadly. Is anyone aware of any key dates or milestones in the next 6 months? I have lost track myself.
I did wonder if consolidation would happen, but was unsure what the trigger would be.
Ok good to know im not alone in my thoughts. Just wish id waited a couple of weeks to top up. Thats my only concern. Agree this should be the rot stopped and the biggest problem was perhaps the question of "how many shares will be converted, what price and how many". Positive that the unknown has for now been removed. They can crack on with the excellent science.
Sooo. Back of a fag box. 979,749,321 shares in issue. 1.8p this morning. Market Cap £18M.
No more CLNs. Obvious increased risk of profit taking with massive dilution, however with the CLNs removed surely all it takes is some positive news on a single candidate to change market perception. Perhaps had to hit rock bottom any my gut is that this is it. Am I way off here or is this more or less the situation? Im currently 68 down but if holding for next 13 months im not concerned and happy about the RNS today as the Mint situation was unsustainable.
This board cracks me up. For comedy value its maybe worth being in for the ride despite being down 50%.
Yeah there is no denying the silence. We know the wheels of industry turn slowly though and maybe peoples expectations are a little too optimistic, gwtting in a froth every day a positive RNS isn't released. I think they are guilty of being too optimistic with some past statements and I agree the silence now doesn't put them in a gokd light. Keeping the faith that this will come good. Hope for my own sake too you do indeed end up with egg on your face.
Ah. Ok, good to know someone else is having the same thoughts. Didn't see that post. Its a busy board!
Good morning long time sufferers.
I was checking through old RNSs and nkted that on 18/2/21 they noted that a Strategic Review was to be undertaken to identify "how to employ the funds raised last year to focus on and develop the most attractive opportunities among the large number now presenting themselves, alongside the investment that has been required to manufacture masks". They also noted that this review should have been completed prior to announcement of the company accounts for the year 31 Dec 20.
2 questions here then. Its the end of Q1 21 so one would expect these accounts to have been published already or have I missed them.
Secondly, im wondering where the output of this strategic review is, again if ive not somehow missed it? Im guessing if not this is really the document that a lot of investors would want to see. It would no doubt also highlight progress with Pharm2Pharm and masks specifically? All speculation, but it would be poor form to announce that a review will be undertaken and then not announce the results? Understand its not incumbent upon them to announce if its not market sensitive but if it describes near term targets it may be? Interesting to hear people's thoughts on this?
Hoping for a rerate in any case. GLA